These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33316936)

  • 1. Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction.
    Zhao F; Vakhrusheva O; Markowitsch SD; Slade KS; Tsaur I; Cinatl J; Michaelis M; Efferth T; Haferkamp A; Juengel E
    Cells; 2020 Dec; 9(12):. PubMed ID: 33316936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells.
    Zhou X; Chen Y; Wang F; Wu H; Zhang Y; Liu J; Cai Y; Huang S; He N; Hu Z; Jin X
    Chem Biol Interact; 2020 Nov; 331():109273. PubMed ID: 33002460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway.
    Rutz J; Maxeiner S; Juengel E; Chun FK; Tsaur I; Blaheta RA
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
    Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis.
    Markowitsch SD; Schupp P; Lauckner J; Vakhrusheva O; Slade KS; Mager R; Efferth T; Haferkamp A; Juengel E
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33121039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemisinin induces selective and potent anticancer effects in drug resistant breast cancer cells by inducing cellular apoptosis and autophagy and G2/M cell cycle arrest.
    Guan X; Guan Y
    J BUON; 2020; 25(3):1330-1336. PubMed ID: 32862573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.
    Quan Y; Lei H; Wahafu W; Liu Y; Ping H; Zhang X
    Biomed Pharmacother; 2019 Dec; 120():109490. PubMed ID: 31574376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.
    Zhang J; Zhou Q; Xie K; Cheng L; Peng S; Xie R; Liu L; Zhang Y; Dong W; Han J; Huang M; Chen Y; Lin T; Huang J; Chen X
    J Exp Clin Cancer Res; 2021 Jun; 40(1):203. PubMed ID: 34154613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling.
    Chen Y; Wang F; Wu P; Gong S; Gao J; Tao H; Shen Q; Wang S; Zhou Z; Jia Y
    Cell Signal; 2021 Dec; 88():110167. PubMed ID: 34628002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells.
    Greenshields AL; Fernando W; Hoskin DW
    Exp Mol Pathol; 2019 Apr; 107():10-22. PubMed ID: 30660598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artesunate Exhibits Synergy With Cisplatin and Cytotoxicity for Upper Tract and Bladder Urothelial Carcinoma Cells.
    Chen SY; Chao CN; Huang HY; Zhao PW; Fang CY
    Anticancer Res; 2023 Mar; 43(3):1175-1184. PubMed ID: 36854526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells.
    Vakhrusheva O; Erb HHH; Bräunig V; Markowitsch SD; Schupp P; Baer PC; Slade KS; Thomas A; Tsaur I; Puhr M; Culig Z; Cinatl J; Michaelis M; Efferth T; Haferkamp A; Juengel E
    Front Oncol; 2022; 12():789284. PubMed ID: 35198441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artesunate induces G0/G1 cell cycle arrest and iron-mediated mitochondrial apoptosis in A431 human epidermoid carcinoma cells.
    Jiang Z; Chai J; Chuang HH; Li S; Wang T; Cheng Y; Chen W; Zhou D
    Anticancer Drugs; 2012 Jul; 23(6):606-13. PubMed ID: 22421370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101).
    Mani J; Vallo S; Rakel S; Antonietti P; Gessler F; Blaheta R; Bartsch G; Michaelis M; Cinatl J; Haferkamp A; Kögel D
    BMC Cancer; 2015 Apr; 15():224. PubMed ID: 25885284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway.
    Wang G; Cao R; Wang Y; Qian G; Dan HC; Jiang W; Ju L; Wu M; Xiao Y; Wang X
    Sci Rep; 2016 Oct; 6():35783. PubMed ID: 27779188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Antiproliferative and Modulatory Effects of 1-Methoxyisobrassinin on Ovarian Cancer Cells: Insights into Cell Cycle Regulation, Apoptosis, Autophagy, and Its Interactions with NAC.
    Zigová M; Miškufová V; Budovská M; Michalková R; Mojžiš J
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temsirolimus improves cytotoxic efficacy of cisplatin and gemcitabine against urinary bladder cancer cell lines.
    Pinto-Leite R; Arantes-Rodrigues R; Ferreira R; Palmeira C; Colaço A; Moreira da Silva V; Oliveira P; Lara Santos L
    Urol Oncol; 2014 Jan; 32(1):41.e11-22. PubMed ID: 24035472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer.
    Lin W; Sun J; Sadahira T; Xu N; Wada K; Liu C; Araki M; Xu A; Watanabe M; Nasu Y; Huang P
    Int J Biol Sci; 2021; 17(12):3255-3267. PubMed ID: 34421363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of androgen receptor inhibitor and cisplatin, an effective treatment strategy for urothelial carcinoma of the bladder.
    Tyagi A; Chandrasekaran B; Kolluru V; Rai S; Jordan AC; Houda A; Messer J; Ankem M; Damodaran C; Haddad A
    Urol Oncol; 2019 Jul; 37(7):492-502. PubMed ID: 31006613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells.
    Babcook MA; Sramkoski RM; Fujioka H; Daneshgari F; Almasan A; Shukla S; Nanavaty RR; Gupta S
    Cell Death Dis; 2014 Nov; 5(11):e1536. PubMed ID: 25412314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.